AcuCort CEO to Discuss Rights Issue and US Expansion in Live Broadcast
AcuCort announced that CEO Jonas Jönmark will participate in a live interview on Tuesday, October 6, at 12:00 PM CET. The discussion will cover the company's rights issue and its US market expansion.
AcuCort CEO Jonas Jönmark is scheduled to participate in a live broadcast on Tuesday, October 6, at 12:00 PM CET. The interview will focus on the company's ongoing rights issue and its strategic expansion into the United States market.
During the interview, Jönmark will explain how the proceeds from the rights issue will be allocated. He is also expected to provide an update on the preparations for the New Drug Application (NDA) submission for Zeqmelit® to the U.S. Food and Drug Administration (FDA), as well as the company's plans for a potential future launch in the US.
The discussion will also touch upon AcuCort's key upcoming milestones. The rights issue is intended to secure the necessary funding for the company's expansion and regulatory processes in the significant U.S. pharmaceutical market.